| P50 | author | David R. Snydman | Q47739390 |
| | Elizabeth A. Pomfret | Q112328072 |
| P2093 | author name string | Tomas Ganz | |
| | Robin Ruthazer | |
| | Mark E Westerman | |
| | Mary Ann Simpson | |
| | Fredric D Gordon | |
| | Jennifer K L Chow | |
| P2860 | cites work | IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin | Q24568204 |
| | A new equation to estimate glomerular filtration rate | Q24651973 |
| | Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C | Q27478403 |
| | Iron homeostasis in host defence and inflammation | Q28083811 |
| | Definitions of cytomegalovirus infection and disease in transplant recipients | Q28210268 |
| | Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein | Q28214986 |
| | The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation | Q29620394 |
| | Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia | Q30252780 |
| | Incidence of prolonged length of stay after orthotopic liver transplantation and its influence on outcomes | Q33412458 |
| | Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies | Q33898647 |
| | Increased serum iron levels and infectious complications after liver transplantation. | Q33965296 |
| | Fever and reduced iron: their interaction as a host defense response to bacterial infection | Q34058159 |
| | Distinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infections | Q34082628 |
| | Microbial siderophore-mediated transport | Q34526524 |
| | Acquisition of iron from host proteins by the group A streptococcus | Q35533007 |
| | Suppression of hepcidin during anemia requires erythropoietic activity | Q35848905 |
| | Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4. | Q35990728 |
| | Reduced serum hepcidin levels in patients with chronic hepatitis C. | Q37387659 |
| | The Effect of pH upon Human Transferrin: Selective Labelling of the Two Iron-binding Sites | Q39080353 |
| | Endogenous hepcidin and its agonist mediate resistance to selected infections by clearing non-transferrin-bound iron. | Q39488378 |
| | CDC definitions for nosocomial infections, 1988 | Q39605670 |
| | Late hepatic artery thrombosis after orthotopic liver transplantation | Q40557742 |
| | Nutritional immunity. Host's attempt to withold iron from microbial invaders | Q40899201 |
| | Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression | Q40990991 |
| | Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus | Q41543544 |
| | Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis | Q42048353 |
| | Serum iron parameters in the early post-transplant period and infection risk in kidney transplant recipients | Q42248581 |
| | The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland. | Q42662774 |
| | Infection and associated risk factors in the immediate postoperative period of pediatric liver transplantation: a study of 176 transplants. | Q43852240 |
| | Clinical significance of serum hepcidin-25 levels in predicting invasive fungal disease in patients after transplantation | Q44973703 |
| | The clinical impact of ganciclovir prophylaxis on the occurrence of bacteremia in orthotopic liver transplant recipients. | Q45115463 |
| | Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo | Q45896455 |
| | The effect of iron compounds on the virulence of Escherichia coli for guinea-pigs | Q47805869 |
| | Association of hepatic iron overload with invasive fungal infection in liver transplant recipients. | Q50479060 |
| | Immunoassay for human serum hepcidin | Q56489921 |
| | Clinical Significance of Serum Hepcidin Levels on Early Infectious Complications in Allogeneic Hematopoietic Stem Cell Transplantation | Q57918471 |
| | Iron status following trauma, excluding burns | Q71547272 |
| | Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality | Q71762003 |
| | Association of fungal infection and increased mortality in liver transplant recipients | Q74127650 |
| | Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiency | Q77601954 |
| | Candida infection in pediatric liver transplant recipients | Q77748020 |
| | Iron-source preference of Staphylococcus aureus infections | Q80551515 |
| | Hepatic iron content and the risk of Staphylococcus aureus bacteremia in liver transplant recipients | Q80608573 |
| | Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS | Q81734651 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1541-1552 | |
| P577 | publication date | 2017-12-01 | |
| P1433 | published in | Liver Transplantation | Q15730498 |
| P1476 | title | Iron-related markers are associated with infection after liver transplantation | |
| P478 | volume | 23 | |